January 18, 2021 News by Forest Ray PhD Compound That Mimics Thyroid Hormone Prevents MS Nerve Damage in Mice A thyroid hormone-mimicking compound not only prevented nerve cell damage but promoted the cells’ survival in a mouse model of multiple sclerosis (MS). This discovery advances previous research showing that the compound, called sobetirome, can induce the repair of myelin, the protective sheath around nerves. The data suggest…
April 22, 2020 News by Joana Carvalho, PhD Nimodipine Can Prevent Spasticity Following Spinal Cord Injury, Mouse Study Shows Nimodipine, an approved medication to prevent brain damage caused byĀ hemorrhage, can be used to prevent spasticity following a spinal cord injury, a mouse study shows. In addition to spinal cord injury, nimodipine may be a promising treatment for neurodegenerative disorders such asĀ multiple sclerosis (MS) and…
September 19, 2019 News by Jose Marques Lopes, PhD JK Rowling Donates Ā£15.3M to UK Clinic Working in MS Research, Treatment Discovery J.K. Rowling, the author of the Harry Potter series, has donated Ā£15.3 million ā more than $19 million ā to the Anne Rowling Regenerative Neurology Clinic to support research, create new facilities, and help develop new treatments for people with multiple sclerosis (MS) and other neurodegenerative disorders.
January 10, 2019 News by Patricia Inacio, PhD Common Fungal Infection Can Breach the Brain and Impair Memory, Mouse Study Shows Blood infection with the yeastĀ Candida albicans,Ā a type of fungus, can reach the brain and trigger an immune response, a new mouse study shows.Ā Although the fungus can be cleared within 10 days, it affects the spatial memory of mice. These findings are the first evidence that a blood infection with a…
September 14, 2016 News by Kara Elam #ECTRIMS2016 – Oryzon to Present Positive Preclinical Data on Potential MS Therapy Researchers from OryzonĀ will presentĀ efficacy data on the companyās oral epigenetic drugĀ ORY-2001, a potential treatment for multiple sclerosis (MS), at theĀ European Committee for Treatment and Research in Multiple SclerosisĀ (ECTRIMS) congress taking place this week in London. The poster presentation, āLSD1 inhibition, a potential epigenetic therapeutic approach for the…
August 4, 2016 News by Charles Moore Antioxidant Therapies Seen as Promising Approach in Treating MS and Like Diseases A review article published in the British Journal of Pharmacology assesses antioxidant approaches for treating neurodegenerative disorders such as multiple sclerosis, Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis (ALS). The review,Ā “Microglia antioxidant systems and redox signalling,”Ā notes that certain compounds associated with oxidative stress appear to be promising…
November 13, 2015 News by Patricia Silva, PhD MS Patients and Doctors Have a New Way of Working Together A new partnership betweenĀ ARM and HeartToHeart Networks LLCĀ has brought healthcare providers of patients with neurodegenerative disorders, such as multiple sclerosis, a new and secure tool for remote health management. The novel health management (RHM) solution combines technology from both companies. It uses mobile devices adapted with a Trusted…